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Abstract 
 
Background 
There are several existing systematic reviews of prevalence of dementia for mainland China, 
Hong Kong, and Taiwan but several studies have been newly reported. The aim of this study 
is to update prevalence data in this region and test for variation across geographical areas and 
time periods using the new dataset.  
 
Methods  
Twenty prevalence studies identified from World Alzheimer Report 2015 (January 2011–
March 2015) and an updated search (March 2015–February 2017) were added to the original 
dataset (N=76). Meta-regression was used to investigate geographical variation and time 
trends taking methodological factors and characteristics of study population into account and 
estimate prevalence and number of people with dementia by geographical areas. 
 
Results 
Compared to northern China, the prevalence of dementia was lower in the central (-1.0; 
95%CI:-2.2,0.3), south (-1.7; 95%CI:-3.1,-0.3), Hong Kong and Taiwan (-3.0; 95%CI: 
-5.0,-1.0) but appeared to be higher in western China (2.8; 95%CI: 0.1,5.5) after adjusting for 
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methodological variation. The increasing trend from pre-1990 to post-2010 periods was 
considerably attenuated when taking into account methodological factors and geographical 
areas. The updated estimated number of people with dementia in all these areas is 9.5 million 
(5.3%; 95%CI: 4.3,6.3) in the population aged 60 or above. 
 
Conclusions 
Geographical variation in dementia prevalence is confirmed in this update while evidence on 
increasing trends is still insufficient. Different societal development across areas provides an 
opportunity to investigate risk factors at the population level operating across diverse 
lifecourse experiences. Such research could advance global primary prevention on dementia. 
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Key messages 
- This review incorporates 96 prevalence studies of dementia in mainland China, Hong 
Kong and Taiwan from previous systemic reviews and an updated search, including both 
English and Chinese literature published until February 2017.  
- The decreasing prevalence from northern, central and southern China to Hong Kong and 
Taiwan was confirmed in this update. A high prevalence in western China was identified 
in this new analysis.  
- The increasing time trend was substantially attenuated after adjusting for methodological 
variation and geographical areas and regional trends showed considerable fluctuations. 
- The updated estimated number of people with dementia in all these areas is 9.5 million, 
which is higher than the previous estimate (8.4 million). 
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Introduction 
Dementia, a syndrome of cognitive decline and a major cause of disability in older age, has 
become a global public health priority in the context of population ageing.
1,2
 The worldwide 
epidemiology of dementia has been an important topic as it provides fundamental information 
for dementia research, charity lobbying, and policy planning.
1
 Since the turn of the 
millennium, many prevalence studies of dementia have been conducted in low and middle 
income countries with China being amongst these.
 3
 Estimated prevalence and number of 
people with dementia in China have been reported in some multicentre prevalence studies
4-6
 
and systematic reviews.
7-12
 
 
Although the earlier literature suggests a lower prevalence in China compared to Western 
Europe and other high-income countries,
1,7,13
 systematic reviews including more recent 
studies have reported higher estimates and indicated a dramatic increase in prevalence over 
time.
8,9,12
 However, these analyses did not fully take into account methodological features of 
individual studies. Changes in diagnostic criteria and research methods can influence 
dementia case identification considerably and therefore these results might not reflect the true 
prevalence trend in the Chinese older population. In addition, the existing reviews have 
generally estimated the number of people with dementia based on a single set of pooled 
prevalence estimates and have not considered variation within this region.
9,12
 China, Hong 
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Kong, and Taiwan have had very different historical, economic and societal contexts as well 
as various trajectories of life expectancy and health status. Variations within China, one of the 
largest countries in the world, have seldom been fully explored.  
 
Our earlier meta-analytical review has covered the prevalence studies of dementia from 
mainland China, Hong Kong, and Taiwan published before April 2012 and identified 
important methodological factors related to the heterogeneity of prevalence estimates. The 
findings reveal north-south geographical variation and a fluctuating time trend in dementia 
prevalence when taking into account methodological factors.
10,11
 With rising global attention 
to population ageing and dementia, several new prevalence studies have been conducted in 
China, Hong Kong and Taiwan and published in the last five years. This provides an 
opportunity to update prevalence data in these areas and review the findings from previous 
analyses.  
 
Building on our earlier reviews,
10,11
 the analyses here updates the prevalence estimates for 
mainland China, Hong Kong, and Taiwan and investigates whether adding these new data 
changes the results from the previous analyses. 
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Methods 
Literature search and data extraction 
This study included three systematic reviews: our earlier review (up to April 2012),
11
 World 
Alzheimer Report 2015 (January 2011–March 2015)
12
 and an updated search (March 2015–
February 2017). The literature searches were conducted to identify prevalence studies of 
dementia in English (PubMed, Web of Knowledge) and Chinese database (Chinese National 
Knowledge Infrastructure (CNKI), WanFang, and Airiti Library). The same search strategy 
and inclusion/exclusion criteria reported in the earlier review
10
 were used to select included 
studies for World Alzheimer Report 2015
12
 and the update search. The PRISMA guidelines
14
 
were followed and more detailed information on the search strategy is reported in 
Supplementary material S1. Inclusion criteria were: (1) cases were collected by field survey, 
not based on hospital data, (2) the study involved population sampling rather than recruiting 
volunteer participants, (3) the study reported prevalence in the people aged 50 and over, and 
(4) dementia case identification was not solely decided by a screening test and that specific 
instruments and criteria were reported. Studies were excluded if they were: (1) duplicate, (2) 
irrelevant or with other focuses (such as mild cognitive impairment), (3) the results of 
follow-up waves, and (4) those which focused on Chinese populations outside mainland 
China, Hong Kong, and Taiwan. A full list of included and excluded studies is provided in 
Supplementary material S1. 
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Information on study design (sampling method, one/two-stage investigation), methodological 
factors (screening tools, diagnostic criteria and instruments), characteristics of population 
(sample size and response rate, the whole study age range and locations) and results 
(prevalence of all types of dementia and stratified prevalence by age) were extracted from 
each study. The results of a recent study in Hong Kong
15,16
 were obtained from a government 
document as the data of dementia prevalence have not been fully published in peer-review 
journals. Data extracted from the new prevalence studies were added to the earlier 76 studies 
and study quality was assessed based on sample size, study design, response rate and 
diagnostic assessment.
12
 More detailed information on characteristics and quality assessment 
of all included studies is provided in Supplementary material S2. 
 
Geographical areas 
The provinces and cities in mainland China were categorised into three large geographical 
areas: north (Beijing, Hebei, Heilongjiang, Henan, Liaoning, Shaanxi, Shandong, Shanxi and 
Tianjin), central (Anhui, Chongqing, Hubei, Hunan, Jiangsu, Jiangxi, Shanghai, Sichuan and 
Zhejiang) and south (Fujian, Guangdong, Guangxi, Guizhou and Hainan).
10
 Sine the update 
search found additional studies from north-western areas, studies from Xinjiang and Gansu 
were separated and categorised into one group (west). Studies from Taiwan and Hong Kong 
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were combined in one group. One multicentre study
6
 including five study centres (Changchun, 
Beijing, Zhengzhou, Guiyang, and Guangzhou) was categorised in one group with other 
multicentre studies. 
 
Time periods 
Time period was categorized into six groups on the basis of the beginning year of 
investigation (not publication year): before 1990, 1990–1994, 1995–1999, 2000–2004, 2005–
2009, and 2010–2015. Compared to the previous review, the last period group was further 
divided into two groups as the new prevalence studies were generally conducted after 2010. 
For studies that did not report the year of investigation in the paper, the publication year 
minus three years was used as an approximation for the survey date.  
 
Data analysis 
To compare results from the earlier review and this update, the same analytical methods 
reported in the previous analysis
10
 were used to analyse the data. Prevalence estimates 
extracted from individual studies were standardised to the Census Population of China 2010.
17
 
A random-effect meta-analysis was used to calculate pooled estimates of overall prevalence 
among all included studies (age 50 or above) as well as stratified prevalence by five-year age 
groups, gender, methodological factors, geographical areas and time periods. I-square was 
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used to indicate consistency of results across studies.
18
 An age-standardised meta-regression 
was conducted to explore whether the variation in prevalence estimates can be related to 
methodological factors or characteristics of study populations and to investigate difference 
across geographical areas and time periods taking into account study design and 
methodological factors. A univariable model was conducted to identify important 
methodological factors related to variation in prevalence estimates and the models for 
geographical areas and time periods were carried out separately. A multivariable model was 
fitted including geographical areas, time periods and all important methodological factors 
identified from the univariable analysis. To investigate trends in geographically defined areas, 
subgroup analyses was conducted to the 24 studies in Beijing (north) and Shanghai (central), 
the two areas with the earliest studies in the pre-1990 period group, as well as northern and 
central areas. 
 
The results of meta-regression modelling were used to estimate the number of people with 
dementia taking into account methodological factors. Predicted prevalence by the five areas 
was estimated from the full model including methodological factors, geographical areas and 
time periods. These estimates were based on DSM-IV/-IV-R, the relatively new diagnostic 
criteria for dementia among the included studies, and were calculated for the population aged 
60 or above in China and aged 65 or above in Hong Kong and Taiwan due to difference in life 
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expectancy and age range of the included studies. Age-stratified prevalence was calculated 
based on regional estimates from meta-regression modelling and the assumption of doubling 
prevalence with each five year, which has been confirmed by worldwide evidence on 
dementia epidemiology.
1
 The stratified prevalence by 5-year age groups applied to population 
structures in China, Hong Kong and Taiwan. More detailed information on calculation 
methods is provided in Supplementary material S3. 
 
 
Results 
The literature search identified 22 studies published between April 2012 and February 2017. 
Fifteen were in Chinese and seven in English. Two English papers contained the same 
information as the Chinese publications.
19,20
 Information from 20 studies was added to the 
earlier prevalence database. In total, 96 prevalence studies of dementia (76 from the previous 
review) were included in this analysis. Among the 20 new studies, 18 were from China and 
two recent studies were found in Taiwan
30
 and Hong Kong.
15,16
 
 
Among the 96 studies reporting the prevalence of dementia in people aged 50 or above, the 
pooled estimate was 4.4% (95% CI: 4.4, 4.8) with a range from 0.6% to 22.0% (Figure 2). 
The heterogeneity was extremely high (I
2
 = 98.6%). The overall estimates were 3.7% (95% CI: 
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3.2, 4.1) in men and 5.6% (95% CI: 5.0, 6.2) in women. Age-stratified prevalence of dementia 
was approximately doubling every five years of increment of age: 50–54 (95% CI: 0.3%; 95% 
CI: 0.1, 0.7), 55–59 (0.5%; 95% CI: 0.3, 0.7), 60–64 (1.1%; 95% CI: 0.8, 1.4), 65–69 (2.0%; 
95% CI: 1.6, 2.3), 70–74 (3.6%; 95% CI: 3.0, 4.2), 75–79 (5.9%; 95% CI: 5.1, 6.8), 80–84 
(10.9%; 95% CI: 9.3, 12.4), 85–89 (18.5%; 95% CI: 14.5, 22.4), 90+ (28.6%; 95% CI: 24.3, 
32.9). Six studies did not report age-stratified prevalence and therefore age standardisation 
was applied to 90 surveys. The overall estimate of age-standardised prevalence was 4.5% 
(95% CI: 4.1, 4.9; I
2
=98.4%).  
 
As in the previous review, diagnostic criteria, whole study age range, population size and 
sampling method remained important in explaining the heterogeneity across individual studies 
(Model 1, Table 1). Studies using DSM-III/III-R, ICD, CCMD and mixed criteria (pooled 
estimate: 2.5%, 95% CI: 2.1, 2.9) generally reported lower prevalence than those using 
DSM-IV/IV-R and other criteria (pooled estimate: 5.7%; 95% CI: 5.0, 6.5). Pooled estimates 
of prevalence increased with whole study age range. Studies with large sample sizes (5000+) 
reported lower prevalence than those with sample size less than 5000. Studies conducting 
cluster based sampling were likely to report lower prevalence compared to those using other 
types of sampling methods.  
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The unadjusted pooled estimate for northern China (5.4%; 95% CI: 4.3, 6.4) was higher than 
central (3.8%; 95% CI: 3.1, 4.4) and south (3.7%; 95% CI: 3.0, 4.4) but was lower than west 
(9.6%; 95% CI: 4.5, 14.8). Pooled prevalence in Hong Kong and Taiwan was 4.0% (95% CI: 
2.7, 5.4). The prevalence of dementia varied across geographical areas after adjusting for 
study design, methodological factors and year of investigation (Table 1). The absolute 
difference from northern areas was about 1% in central areas (-1.0; 95% CI: -2.2, 0.3), 2% in 
south areas (-1.7; 95% CI: -3.1, -0.3), 3% in Hong Kong and Taiwan (-3.0; 95% CI: -5.0, -1.0) 
and 3% in west areas (2.8%; 95% CI: 0.1, 5.5).  
 
TABLE 1 HERE 
 
Crude prevalence increased from 1.9% (95% CI: 1.0, 2.9) before 1990 to 6.4% (95% CI: 5.2, 
7.7) in 2010–2015 with a clear increasing trend. After adjusting for methodological factors 
and geographical areas, the apparent increasing trend was attenuated (Figure 3(A)). Although 
the adjusted estimate in 2010–2015 (4.9%; 95% CI: 2.8, 7.0) was nearly twice higher than the 
prevalence reported from five studies before 1990 (2.8%, 95% CI: 0.4, 5.2), the variation in 
dementia prevalence after 1990 was unclear and regional trends revealed considerable 
fluctuation across the time periods (Figure 3(B)). In particular, trends in 24 studies from 
Beijing and Shanghai, the only two areas with studies before 1990, showed an even dramatic 
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fluctuation after adjusting for methodological factors.  
 
Based on the results of DSM-IV/IV-R, Table 2 reports estimated numbers of people with 
dementia by geographical areas, which show substantial difference in meta-regression 
modelling. In China, estimated number of people with dementia was 9.5 million in those aged 
60 or over (5.3%, 95% CI: 4.3, 6.3) and 3.5 million were in northern China (5.5%, 95% CI: 
4.3, 6.7). New estimates for people aged 65 or above were 0.07 million in Hong Kong (7.2%, 
95% CI: 5.3, 9.1) and 0.15 million in Taiwan (6.0%, 95% CI: 4.1, 7.9). 
 
TABLE 2 HERE 
 
Discussion 
This updated review has identified 20 prevalence studies in addition to the 76 studies included 
in the earlier review and confirmed geographical variation and time trends reported our the 
previous analyses.
13,14
 The prevalence of dementia decreases from northern, central and 
southern China to the lowest in Hong Kong and Taiwan but a particularly high estimate was 
found in Western China. The apparent increasing prevalence across time is attenuated once 
adjusted for methodological factors and geographical areas. Regional patterns over time 
reveal considerable fluctuations. The current best estimate for number of people with 
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dementia in this region as a whole is 9.5 million (5.3%, 95% CI: 4.3, 6.3) in the population 
aged 60 or above. 
 
Compared to other existing systematic reviews, this analysis investigated geographical 
variation and time trends taking important methodological factors and characteristics of study 
population into account and used regional prevalence estimates and population data to model 
number of people with dementia by different areas. To examine the potential interaction of 
geographies and time, this review further explored regional trends in Beijing and Shanghai 
since the late 1980s. There are some limitations in this review. The three literature searches 
were conducted at different time points due to limited research funding and resources. 
Although this might introduce bias, the updated searches included a short overlapping period 
from the earlier searches in order to ensure the same studies were identified. Results of 
literature searches were also compared with the reference lists of existing systematic reviews. 
The study protocol was not registered or published before the review being conducted but this 
update generally followed the study methods and procedures used in our earlier studies. It is 
possible that unpublished data or local investigations might exist for less developed areas but 
are not available in the public domain. Although some new investigations have been 
conducted in north-western provinces, most studies are concentrated in Shanghai and 
relatively wealthy areas. The current estimates are still mainly based on the studies existing in 
17 
 
highly developed areas and from the indicators of regional variation these might not fully 
represent substantial variation across China. Although the analysis investigated potential 
sources of heterogeneity, considerable inconsistency of prevalence estimates across studies 
could not be fully explained by methodological variation. It is possible that some unmeasured 
factors and characteristics of study population such as mortality might influence prevalence 
estimates in the study population but such information could not be extracted from the 
publications. The number of people with dementia was calculated based on the modelling 
results and therefore estimates are sensitive to small differences in regression coefficients. 
Although changes in prevalence did not achieve statistical significance, the numbers 
calculated using the time point estimate will still vary substantially because of the sheer size 
of the Chinese older population. 
 
The study quality was not related to variation in prevalence estimates and did not 
considerably change over time. However, most two-stage studies did not include a sample of 
screen negatives and appropriate weights. The quality of reporting also varied across 
individual studies. For example, although two-thirds of studies had high response rates 
(>80%), 22% did not report such information and selection bias in these studies was unknown. 
Some short reports did not provide detailed information on research methods or study 
populations. Such lack of detail may lead to unexplained heterogeneity in the meta-analysis. 
18 
 
In addition, a relatively small number of studies (9%) used comprehensive diagnostic 
assessment, including multi-domain cognitive tests, disability assessment, informant and 
clinical interviews. Implementation of dementia diagnosis might be compromised due to 
incomplete information on cognitive and functional status. 
 
The 20 new studies contributed a quarter of the total database and continue to highlight 
potential variation in cognitive health within East Asia. Our earlier review and this update 
suggest similar findings of geographical variation: prevalence estimates were higher in the 
north with lower estimates further south after adjustment for methodological factors. In 
addition, studies from western China appear to provide distinct estimates compared to the 
north in this new analysis and showed a particularly high pooled estimate. This might indicate 
a complicated and prolonged influence of societal contexts on individual life experiences, 
behaviours and health conditions, which may affect health and cognition in later life. Regional 
differences in lifecourse exposures such as education, smoking, nutrition and dietary
31
 as well 
as potential environmental risk factors such as sunshine and Vitamin D intake,
32
 air 
pollution,
33
 and health services
34
 may play a part in general health and subsequent risk of 
dementia and provide a possible explanation on geographical variation. In particular, Uyghur 
and other ethnic minority in western areas have very different lifestyle, culture and 
environment from the Han Chinese and generally experience high levels of deprivation.
35
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Variation in education, general health and life experiences between Uyghur and Han might 
contribute to differences in cognitive health at older ages. Urban and rural differences have 
been reported in a recent multicentre study
6
 but the analysis here could not explore specific 
estimates for urban-rural areas due to different definitions of urban and rural settings across 
studies. Improving reporting on geographical locality characteristics would enable this to be 
explored further. 
 
The new studies have provided more data on prevalence estimates in the last five years. The 
unadjusted pooled prevalence has increased over time with the highest in the most recent 
period group (2010–2015) but this difference can be largely attributed to changes in 
diagnostic criteria and study methods as well as geographical variation within China. The 
findings confirm an increasingly recognised phenomenon of the major influence of diagnostic 
methods on prevalence estimates.
36
 Further adjustment for geographical areas and subgroup 
analyses on regional trends also considerably attenuated increasing prevalence across time. 
Although the adjusted estimate in 2010–2015 was twice as high as the one for the oldest 
group (before 1990), the estimate from pre-1990 period is highly atypical as these early 
studies only focused on relatively small areas in metropolitan cities (Beijing and Shanghai). 
The research context of these old investigations is therefore very different from more recent 
studies. In particular, the second edition of the Chinese Classification of Mental Disorders 
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(CCMD-2) was published in 1989.
37
 Development of psychiatric knowledge and the 
adaptation of new criteria changes case identification and prevalence estimates across time. 
Although several existing reviews have suggested that the prevalence of dementia might have 
increased across time given the rising incidence of chronic conditions such as diabetes, 
vascular diseases and metabolic syndrome,
12,38
 the scale of increase cannot be determined 
unless the effect of different diagnostic criteria and methodologies can be accounted for first. 
What is unclear in all the changes to diagnostic criteria over the time periods is how 
differently each set of diagnostic criteria predicts natural history and, indeed, whether the 
most recent changes lead to greater misclassification (i.e. more false positives).  
 
Despite marginal changes in prevalence estimates, the new estimated number of people (9.5 
million) is one million higher than the previous estimate (8.4 million). In the World Alzheimer 
Report 2015, the estimate for East Asia was 9.8 million based on recent studies in China 
(published after 2005).
12
 Although these differences reflect different statistical aspects of 
estimation and varying sources of standard population data, small changes in prevalence 
estimates could indicate enormous impact on health and social care systems and whole society. 
The changing meaning of dementia diagnoses and measurement modalities needs close 
attention as an increase of one million people at the very mild end of the spectrum which may 
include false positives or people with low likelihood of progression has very different 
21 
 
implication for society compared with one million moderate to severely affected people.  
 
Although population ageing, changes in lifestyle and rise in chronic diseases might increase 
the risk of dementia in older populations,
31
 recent epidemiological studies in high income 
countries have reported stable or reduced prevalence of dementia over the last two decades.
39
 
Possible explanation on these decreasing trends has been related to the improvement of 
education, living conditions, lifestyle and reduction in chronic conditions.
40
 Although overall 
prevalence trends in mainland China, Hong Kong, and Taiwan are uncertain due to the 
substantial impact of methodological variation, geographical variation within this region 
might provide an opportunity to investigate these hypotheses. Differences in economic and 
societal development across China may be potential contexts for natural experiment research.  
 
High-quality primary research is needed in this region in order to provide robust prevalence 
estimates and evidence for policy planning. In recent years, international organisations and 
civil societies have focused on promoting national plans on dementia.
41
 In addition to these 
dementia-specific policies, public health policy planning needs to adopt a comprehensive 
approach to improve general health in populations and address determinants of cognitive 
health across lifecourse to inform prevention or risk reduction strategies.
40
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Table 1. Meta-regression: the relationships between prevalence estimates, methodological factors, geographical areas and time periods 
   Model 1   Model 2   Model 3   Model 4  
  Coeff. 95% CI p. Coeff. 95% CI p. Coeff. 95% CI p. Coeff. 95% CI p. 
Diagnostic  DSM-III/-III-R (ref. a.) - - <0.01 - - <0.01 - - <0.01 - - <0.01 
criteria b. DSM-IV/-IV-R 3.16 (1.93, 4.40)  2.35 (1.27, 3.44)  2.42 (0.79, 4.05)  2.06 (0.54, 3.58)  
 ICD-10 1.72 (-0.64, 4.09)  0.74 (-1.24, 2.73)  0.57 (-1.86, 2.99)  0.39 (-1.80, 2.58)  
 CCMD 0.69 (-1.67, 3.05)  -0.80 (-2.87, 1.27)  -0.60 (-3.20, 2.00)  -1.20 (-3.51, 1.10)  
 Mixed 2.31 (0.51, 4.10)  1.33 (-0.25, 2.90)  1.99 (0.01, 3.97)  1.54 (-0.25, 3.34)  
 Other 5.30 (3.23, 7.36)  3.29 (1.44, 5.14)  4.04 (1.64, 6.44)  3.25 (1.08, 5.42)  
              
Whole study 50+ -2.62 (-6.58, 1.33) <0.01 -3.41 (-6.58, -0.23) <0.01 -0.70 (-4.27, 2.88) 0.01 -2.49 (-5.85, 0.88) <0.01 
age range 55+ -1.28 (-2.91, 0.35)  -0.97 (-2.29, 0.35)  -1.03 (-2.47, 0.41)  -0.62 (-2.00, 0.76)  
 60+ (ref. a.) - -  - -  - -  - -  
 65+ 1.57 (0.18, 2.97)  1.51 (0.36, 2.67)  1.25 (-0.07, 2.56)  1.45 (0.23, 2.67)  
 70+ 3.44 (-0.60, 7.47)  3.79 (0.66, 6.92)  4.21 (0.67, 7.75)  4.81 (1.49, 8.13)  
              
Sampling  Cluster-based (ref. a.) - -  - -     - -  
method Individual-based 1.96 (0.55, 3.37) 0.02 1.09 (-0.12, 2.30) 0.21 0.98 (-0.20, 2.16) 0.25 1.04 (-0.16, 2.25) 0.23 
 Unknown -0.24 (-3.65, 3.18)  0.31 (-2.24, 2.87)  -0.21 (-3.04, 2.63)  0.38 (-2.20, 2.96)  
              
Study size Less than 5000 (ref. a.) - -  - -     - -  
 More than 5000 -1.99 (-3.45, -0.54) 0.01 -1.35 (-2.49, -0.20) 0.02 -1.64 (-2.87, -0.45) <0.01 -1.29 (-2.43, -0.14) 0.03 
              
Area North (ref. a.) - - <0.01 - - <0.01    - -  
 Central -1.56 (-3.03, -0.08)  -0.66 (-1.83, 0.51)     -0.96 (-2.18, 0.27) <0.01 
 South -1.53 (-3.27, 0.21)  -1.31 (-2.62, 0.01)     -1.70 (-3.10, -0.31)  
 Hong Kong and Taiwan -1.40 (-3.54, 0.75)  -2.49 (-4.35, -0.63)     -3.02 (-5.01, -1.04)  
 West 3.93 (0.88, 6.97)  3.57 (0.93, 6.22)     2.76 (0.05, 5.47)  
 Multicentre 0.37 (-2.97, 3.71)  -0.02 (-2.63, 2.59)     -0.22 (-2.87, 2.43)  
              
Year of 2010-2013 (ref. a) - - <0.01    - - 0.05 - - 0.08 
Investigation 2005-2009 -0.95 (-2.84, 0.93)     -1.18 (-2.75, 0.40)  -0.86 (-2.35, 0.62)  
 2000-2004 -2.33 (-4.40, -0.27)     -1.58 (-3.36, 0.19)  -1.00 (-2.66, 0.67)  
 1995-1999 -2.45 (-4.17, -0.72)     -1.82 (-3.42, -0.23)  -1.61 (-3.11, -0.11)  
 1990-1994  -3.09 (-5.06, -1.11)     -1.56 (-3.79, 0.67)  -0.42 (-2.69, 1.84)  
 Before 1990 -4.39 (-7.17, -1.62)     -1.91 (-4.49, 0.67)  -2.12 (-4.56, 0.32)  
I2     96.1%   96.2%   96.0%   
30 
 
a. 
Ref.: reference group 
b.
 Diagnostic criteria: DSM-III/ -IV: Diagnostic and Statistical Manual of Mental Disorder Third/ Fourth Edition; ICD-9/ 10: the International 
Statistical Classification of Diseases 9
th
/10
th
; CCMD: Chinese Classification of Mental Disease; Mixed: multiple diagnostic criteria including 
DSM, ICD or CCMD; Other: 10/66 diagnosis algorithm, Geriatric Mental Status and the algorithm of the Automatic Geriatric Examination for 
Computer Assisting Taxonomy (GMS-AGECAT), National Institute on Aging–Alzheimer's Association guidelines (NIA-AA)  
p.: p-value of F-test, except year of investigation, which reports p-value of test for trend; Model 1: univariable model; Model 2: adjusted model 
including area and methodological factors; Model 3: adjusted model including year of investigation and two important methodological factors, 
diagnostic criteria and whole study age range; Model 4: adjusted model including methodological factors, year of investigation and 
geographical area 
I
2
: I-square of meta-regression; indicator of heterogeneity 
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Table 2. Estimated numbers of people with dementia in mainland China, Hong Kong and Taiwan (million) based on DSM-IV/IV-R 
criteria 
Area Older population
a.
 
 
Number of people with 
dementia (million) 
Prevalence  
(%, 95% CI) 
China North 63.9 3.52 5.5 (4.3, 6.7) 
(age 60+) 
a.
 Central 73.3 3.79 5.2 (4.0, 6.4) 
 South 30.9 1.48 4.8 (3.5, 6.1) 
 West 9.5 0.69 7.2 (4.6, 9.8) 
 Total 177.6 9.48 5.3 (4.3, 6.3) 
Hong Kong
 
 
(age 65+)
 a. 
 
0.9 0.07 7.2 (5.3, 9.1) 
Taiwan
  
(age 65+)
 a.
 
 
2.5 0.15 6.0 (4.1, 7.9) 
Total  181.0 9.70 5.3 (4.3, 6.3) 
 
a. The estimation for Hong Kong and Taiwan focused on the population aged 65 or over as most studies in these two areas recruited participants 
aged 65 or over. 
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Figure 1. Flow chart of literature search 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
World Alzheimer Report 2015 (January 2011– March 2015) 
Chinese databases (CNKI, Wanfang, Airti Library) N=2612 
English databases (PubMed, Web of Science) N=1083 
 
 
 
 
 
Title/abstract screening 
Journal article: 2842 
Conference: 71 
Removed duplicated 
papers N=782 
Full text review 
46 journal articles 
7 included in the 
earlier review [11] 
Eligible studies 
Prevalence: 21 
Incidence*: 2 
24 excluded according 
to inclusion/exclusion 
criteria 
Search terms*: (癡呆 OR 失智(dementia) OR 阿爾茨海
默(Alzheimer) AND (患病率 OR 盛行率(prevalence) OR
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Update search (March 2015 –February 2017) 
Chinese databases (CNKI, Wanfang, Airti Library) N=747 
English databases (PubMed, Web of Science) N=343 
 
 
 
 
 
Title/abstract screening 
Journal article: 774 
Removed duplicated 
papers N=316 
Full text review 
12 journal articles 
7 excluded according 
to inclusion/exclusion 
criteria 
Search terms*: (癡呆 OR 失智(dementia) OR 阿爾茨
海默(Alzheimer) AND (患病率 OR 盛行率(prevalence) 
OR 流行(epidemiology)) 
5 studies 
Studies included in the 
earlier systematic review
11
 
(January 1980–April 2012) 
N=76 
96 prevalence studies 
*Search terms further included ‘incidence’ for the collaboration of the World Alzheimer Report 2015.
12
 Both simplified and traditional Chinese characters were 
used in the search. More detailed information on the search strategy and included/excluded studies is provided in S2 Supporting Information. 
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Figure 2. Forest plot of crude prevalence (N=96) 
  NOTE: Weights are from random effects analysis
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Figure 3. Prevalence of dementia in the population aged 60 or above across time periods  
(A) All included studies 
 
 
Adjusted: adjusted for diagnostic criteria, whole study age range, sampling method, population size and 
geographical areas; Test for trend: Unadjusted p<0.01; Adjusted p=0.08 
 
(B) Subgroup analysis: regional trends in China 
 
 
Beijing and Shanghai (N=24): Beijing and Shanghai were the two highly developed areas with studies before 
1990; North (N=24): all studies from northern China; Central (N=33): all studies from central China; There were 
insufficient observations for southern and western China, Hong Kong and Taiwan. All estimates adjusted for 
diagnostic criteria, whole study age range, sampling method and population size 
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